Regeneron Pharmaceuticals, Inc.

Erste Asset Management GmbH REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

52,049

Value ($000)

40,471

Weight

0.3%

2018 Q4 - 2025 Q4 (29 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	40,471	0.3%	52,049	12/31/2025
2025 Q3	11/12/2025	27,329	0.3%	48,736	9/30/2025
2025 Q2	8/14/2025	27,879	0.2%	53,397	6/30/2025
2025 Q1	5/14/2025	23,565	0.3%	37,033	3/31/2025
2024 Q4	2/10/2025	28,646	0.4%	40,382	12/31/2024
2024 Q3	11/14/2024	42,480	0.5%	40,639	9/30/2024
2024 Q2	11/26/2024	40,808	0.5%	38,833	6/30/2024
2024 Q1	11/26/2024	40,534	0.6%	41,948	3/31/2024
2023 Q4	11/26/2024	36,044	0.5%	40,880	12/31/2023
2023 Q3	11/26/2024	32,106	0.6%	38,470	9/30/2023
2023 Q2	11/26/2024	28,233	0.5%	39,853	6/30/2023
2023 Q1	11/26/2024	32,006	0.6%	39,440	3/31/2023
2022 Q4	11/26/2024	23,188	0.5%	32,148	12/31/2022
2022 Q3	11/26/2024	23,615	0.5%	34,135	9/30/2022
2022 Q2	11/26/2024	19,888	0.4%	33,278	6/30/2022
2022 Q1	11/25/2024	22,295	0.4%	32,201	3/31/2022
2021 Q4	11/25/2024	21,526	0.4%	33,256	12/31/2021
2021 Q3	11/25/2024	21,216	0.4%	34,970	9/30/2021
2021 Q2	11/25/2024	17,182	0.3%	31,470	6/30/2021
2021 Q1	11/25/2024	15,589	0.4%	33,120	3/31/2021
2020 Q4	11/25/2024	15,916	0.4%	32,870	12/31/2020
2020 Q3	11/25/2024	20,461	0.7%	35,670	9/30/2020
2020 Q2	11/22/2024	21,991	0.9%	36,000	6/30/2020
2020 Q1	11/22/2024	4,494	0.3%	9,500	3/31/2020
2019 Q4	11/22/2024	3,547	0.2%	9,500	12/31/2019
2019 Q3	11/22/2024	2,598	0.1%	9,500	9/30/2019
2019 Q2	11/22/2024	2,951	0.2%	9,500	6/30/2019
2019 Q1	11/22/2024	7,024	0.4%	17,350	3/31/2019
2018 Q4	11/26/2024	9,448	0.6%	25,900	12/31/2018